low dose glp-1 Hims Inc Microdosed GLP-1 (Semaglutide)

These findings underscore the need for monitoring as GLP-1 use expands, though overall patient risk remains low

While previous research has shown that stopping GLP-1s can lead to weight gain, this latest study suggests that greater weight loss tends to result in faster weight regain, especially when these blockbuster drugs are involved

They did these at both the start and end of the study

GLP-1R agonists fall under two groups: human GLP-1 backbone agents and exendin-4 backbone agents

Tirzepatide raises it by roughly 2 to 4 beats per minute

Age-dependent human beta cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling